Hypertension in Turner syndrome: a review of proposed mechanisms, management and new directions

J Hypertens. 2023 Feb 1;41(2):203-211. doi: 10.1097/HJH.0000000000003321. Epub 2022 Nov 2.

Abstract

Acquired cardiovascular diseases account for much of the increased risk of premature death in patients with Turner syndrome (TS). Hypertension is a major modifiable cardiovascular risk factor. It has a high prevalence in TS developing at an early age and thus leading to prolonged exposure to high blood pressure. The aetiology for hypertension in TS is largely unknown. It is likely multifactorial, and recent hypotheses include altered sympathetic tone, vasculopathy and endocrine factors. In this review article we aim to provide a comprehensive review of data on mechanisms of hypertension in TS and their implication for diagnostics and optimal choice of antihypertensive treatments. Ultimately this knowledge should help prevent hypertension-related complications, and improve quality of life and life expectancy for patients with TS.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antihypertensive Agents
  • Heart
  • Humans
  • Hypertension* / complications
  • Hypertension* / drug therapy
  • Hypertension* / epidemiology
  • Quality of Life
  • Turner Syndrome* / complications
  • Turner Syndrome* / epidemiology

Substances

  • Antihypertensive Agents